posted on 2014-12-22, 02:57authored byRoberta Maggio, Carmela Viscomi, Paola Andreozzi, Gabriella D'Ettorre, Giovanni Viscogliosi, Barbara Barbaro, Manuele Gori, Vincenzo Vullo, Clara Balsano
In CHC patients, after NLCD, we observed highly significant changes in LXRα, LXRβ and ABCA-1 mRNA levels, respect to before NLCD (A). No significant changes were observed in NAFLD/NASH patients after NLCD (B). Data are expressed as mean ±SD; all samples were assessed in triplicate. Error bars illustrate SD. *P<0.05; **P<0.01.